Excellent 4Q16 results. The updated charts below tell the story.
Operational expenses are markedly down apart from staff expenses, which has seen a one-off increase due to the change from a contract team to the Company’s own sales force. The significant improvement in sell-through to pharmacies is important.
Some serious cash is beginning to flow in, with receipts more than double that of the previous quarter and at 270% compared with a year ago. The FY2016 figure of $3.89M cash receipts is up 248% compared with FY2015.
Net cash outflow for the quarter of $232K is excellent. Previous quarters have averaged a little over $1M in operational cash burn. This has resulted in only a minor change in cash held at the end of the quarter.
Japan already profitable.
There appears to be is every chance of achieving a cash flow positive position by the end of 2016.
- Forums
- ASX - By Stock
- AN1
- Quarterly Trends
Quarterly Trends, page-7
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable